FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

391805000: Azithromycin dihydrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2694022018 Azithromycin dihydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2733830014 Azithromycin dihydrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4742231000005110 azithromycindihydrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin dihydrate Is a Azithromycin (substance) false Inferred relationship Some
Azithromycin dihydrate Is a Substance with macrolide structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Azithromycin dihydrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Azithromycin (substance) true Inferred relationship Some
Azithromycin dihydrate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Azithromycin dihydrate Is a Antibacterial false Inferred relationship Some
Azithromycin dihydrate Is a Macrolide (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Azithromycin dihydrate 250mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 1 g suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 600 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 100 mg/5 ml suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
Azithromycin dihydrate 200mg/ 5 mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 1200 mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
Azithromycin dihydrate 200mg/5 mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycindihydrat 100 mg/ml pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycin 250 mg kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycin 1 g/pakke til oral anvendelse (pulver til rekonstitution) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycin 500 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some
azithromycin 250 mg kapsel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some 1
azithromycin 500 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some 1
azithromycin 500 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 250 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 600 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 600 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 250 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
azithromycin 250 mg kapsel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
azithromycindihydrat 600 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
azithromycin 500 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
azithromycin 500 mg pulver til injektionsvæske, opløsning, hætteglas The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Azithromycin dihydrate Inferred relationship Some 1
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Azithromycin dihydrate Inferred relationship Some 1
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Azithromycin dihydrate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start